체외 대장암 스크리닝 검사 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별(분변잠혈 검사, 바이오마커 검사, CRC DNA 스크리닝 검사), 지역별, 경쟁별(2020-2030년)

The Global In-vitro Colorectal Cancer Screening Tests Market will grow from USD 890.89 Million in 2024 to USD 1069.98 Million by 2030 at a 3.1% CAGR. In-vitro colorectal cancer screening tests involve diagnostic procedures utilizing biological samples like stool or blood to detect colorectal cancer or its precursors, thereby enabling early disease identification crucial for improved treatment outcomes. The market's growth is primarily driven by the increasing global prevalence of colorectal cancer and heightened awareness regarding early detection methods.

Key Market Drivers

The escalating global incidence of colorectal cancer represents a paramount driver for the in-vitro screening tests market. The increasing number of new cases, particularly among younger individuals, highlights a pressing public health demand for accessible and accurate diagnostic tools. This growing disease burden necessitates expanded screening to enable early detection, which is vital for enhancing patient survival and reducing mortality. According to the American Cancer Society, in January 2024, their annual report, "Cancer Statistics, 2024", indicated that colorectal cancer became the leading cause of cancer death in men and the second in women under 50 years old. This escalating incidence directly stimulates demand for improved in-vitro screening methods.

Key Market Challenges

Variable reimbursement policies and the high costs associated with advanced diagnostic technologies present a significant impediment to the expansion of the global in-vitro colorectal cancer screening tests market. These financial barriers restrict patient access to advanced screening options across diverse healthcare systems, particularly when insurance coverage is inconsistent or requires substantial out-of-pocket payments. This directly leads to lower adoption rates, as both healthcare providers and individuals may prioritize more affordable or covered alternatives, even if they are less comprehensive.

Key Market Trends

The growing integration of personalized medicine approaches is a significant trend in colorectal cancer screening, enabling tailored strategies based on individual genetic profiles and risk factors. This facilitates targeted early detection through specific biomarkers. According to the American Cancer Society, in January 2024, their "Cancer Statistics, 2024" report indicated nearly 3% of individuals under 50 diagnosed with colorectal cancer attributed their condition to family history or genetic factors, highlighting the need for individualized screening. Guardant Health, Inc.'s November 2025 report in Current Medical Research and Opinion exemplified this, noting its Shield blood-based screening test achieved 95% patient adherence, showcasing improved compliance with precision diagnostics.

Key Market Players

• Abbott Laboratories, Inc.
• Beckman Coulter, Inc.
• Eiken Chemical Co., Ltd.
• Sysmex Corporation
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• Merck KGaA
• Kyowa Kirin Co., Ltd.
• Randox Laboratories Ltd.
• R-Biopharm AG

Report Scope:

In this report, the Global In-vitro Colorectal Cancer Screening Tests Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In-vitro Colorectal Cancer Screening Tests Market, By Test Type:

• Fecal Occult Blood Tests
• Biomarker tests
• CRC DNA Screening Tests

In-vitro Colorectal Cancer Screening Tests Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In-vitro Colorectal Cancer Screening Tests Market.

Available Customizations:

Global In-vitro Colorectal Cancer Screening Tests Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-vitro Colorectal Cancer Screening Tests Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Fecal Occult Blood Tests, Biomarker tests, CRC DNA Screening Tests)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America In-vitro Colorectal Cancer Screening Tests Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
  • 6.3.2. Canada In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
  • 6.3.3. Mexico In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type

7. Europe In-vitro Colorectal Cancer Screening Tests Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
  • 7.3.2. France In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
  • 7.3.3. United Kingdom In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
  • 7.3.4. Italy In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
  • 7.3.5. Spain In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type

8. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
  • 8.3.2. India In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
  • 8.3.3. Japan In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
  • 8.3.4. South Korea In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
  • 8.3.5. Australia In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type

9. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
  • 9.3.2. UAE In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
  • 9.3.3. South Africa In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type

10. South America In-vitro Colorectal Cancer Screening Tests Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
  • 10.3.2. Colombia In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
  • 10.3.3. Argentina In-vitro Colorectal Cancer Screening Tests Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global In-vitro Colorectal Cancer Screening Tests Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Beckman Coulter, Inc.
• 15.3. Eiken Chemical Co., Ltd.
• 15.4. Sysmex Corporation
• 15.5. Siemens Healthineers AG
• 15.6. Quest Diagnostics Incorporated
• 15.7. Merck KGaA
• 15.8. Kyowa Kirin Co., Ltd.
• 15.9. Randox Laboratories Ltd.
• 15.10. R-Biopharm AG

16. Strategic Recommendations

17. About Us & Disclaimer